Interactions of CD80 and CD86 with CD28 and CTLA4

Journal of Immunology

Volumn 156, Issue 8, 1996, Pages 2700-2709

  Ellis, Jonathan H ^a   Burden, M Neil ^a   Vinogradov, Dimitri V ^a,b   Linge, Claire ^a,c   Crowe, J Scott ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANTIBODY CONJUGATE; B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, HUMAN; CD86 PROTEIN, RAT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; EPITOPE; LEUKOCYTE ANTIGEN; LIGAND; MEMBRANE PROTEIN; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING COMPETITION; CELL CULTURE; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; RAT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; BINDING, COMPETITIVE; CELLS, CULTURED; CONSERVED SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; IMMUNOCONJUGATES; LIGANDS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PROTEIN BINDING; RATS; SIGNAL TRANSDUCTION;

EID: 0030584777     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Weiss, A , and J. B Imboden. 1987. Cell surface molecules and early events involved in human T lymphocyte activation. Adv. Immunol. 41:1
2. Allison, J P. 1994. CD28-B7 interactions in T-cell activation. Curr. Opin. Immunol. 6:414.
3. Peri, K. G., and A Veillette. 1994. Tyrosine protein kinases in T lymphocytes. Chem Immunol 59:19.
4. Quill, H., and R. H Schwartz 1987 Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative non-responsiveness. J. Immunol. 138: 3704
5. Mueller, D. L., M. K. Jenkins, and R H Schwartz. 1989 An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness. J. Immunol. 142:2617.
6. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz 1989. Clonal expansion versus functional clonal inactivation a cosumulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445.
7. DeSilva, D R , K. B. Urdahl, and M. K Jenkins. 1991. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J. Immunol. 147:3261.
8. Harding, F A., J. G McArthur, J. A. Gross, D H. Raulet, and J. P. Allison 1992. CD28-mediated signalling costimulates murine T cells and prevents induction of anergy in T cell clones. Nature 356.607.
9. van Seventer, G. A., W. Newman, Y. Shimizu, T. B. Nutman, Y. Tanaka, K J. Horgan, Y. V. Gopal, E Ennis, D. O'Sullican, H Grey, and S. Shaw. 1991. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1 but not ELAM-1 J. Exp. Med 174.901.
10. June, C. H., P. Vandenburghe, and C B. Thompson 1994. The CD28 and CTLA-4 receptor family Chem. Immunol. 59:62.
11. Freeman, G. J , A S Freedman, J M. Segil, G Lee, J. F. Whitman, and L M. Nadler. 1989 B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 143:2714.
12. Freeman, G. J., F Borriello, R. J Hodes, H. Reiser, J G. Gribben, J. W. Ng, J Kim, J M. Goldberg, K. Hathcock, G. Laszlo, L A. Lombard, S. Wang, G. S. Gray, L. M Nadler, and A H. Sharpe. 1993 Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production J Exp Med. 178:2185.
13. Freeman, G. J., J. G. Gribben, V A. Boussiotis, J W. Ng, V. A. Restivo, L. A. Lombard, G S. Gray, and L M. Nadler. 1993. Cloning of B7-2: a CTLA4 counter-receptor that costimulates human T cell proliferation. Science 262.909.
14. Azuma, M., D Ito, H Yagita, K. Okumura, J. H. Phillips, L. L. Lanier, and C Somoza. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76.
15. Caux, C., B. Vanbervliet, C. Massacrier, M. Azuma, K. Okumura, L. Lamer, and J. Banchereau. 1994, B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J. Exp. Med. 180.1841.
16. Galvin, F., G. J. Freeman, Z. Razi-Wolf, W J Hall, B. Benacerraf, L. Nadler, and H. Reiser. 1992 Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation. J. Immunol. 149:3802
17. Judge, T. A., M. Liu, P. J Christensen, J. J. Fak, and L. A. Turka. 1995 Cloning the rat homolog of the CD28/CTLA4-ligand B7-1: structural and functional analysis Int. Immunol. 7:171.
18. Linsley, P. S., W. Brady, L Grosmaire, A. Aruffo, N. K. Damle, and J. A. Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:721.
19. June, C. H., J. A. Ledbetter, P. S. Linsley, and C. B Thompson. 1990 Role of CD28 receptor in T cell activation. Immunol. Today 11:211.
20. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
21. Linsley, P. S., W. Brady, M. Urnes, L. S Grosmaire, N. K. Damle, and J. A Ledbetter. 1991. CTLA4 is a second receptor for the B cell activation antigen B7 J. Exp. Med 174:561.
22. Freeman, G J., G. S. Gray, C. D. Gimmi, D. B. Lombard, L. J. Zhou, M. White, J. D. Fingeroth, J G Gribben, and L. M. Nadler. 1991 Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp. Med. 174:625
23. Peach, R. J., J. Bajorath, W. Brady, G. Leytze, A Greene, J Naemura, and P. S. Linsley. 1994 Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA4 and CD28 determine the binding to B7-1. J. Exp. Med 180:2049.
24. Linsley, P. S., P. M. Wallace, J. Johnson, M G. Gibson, J. L Greene, J. A. Ledbetter, C. Singh, and M A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257:792.
25. Corry, D B., S L Reiner, P. S. Linsley, and R M. Locksley 1994. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis J Immunol. 153:4142.
26. Wallace, P M., J. S. Johnson, J. F. MacMaster, K. A Kennedy, P. Gladstone, and P. S. Linsley. 1994. CTLA4Ig treatment ameliorates the lethality of murine graftversus-host disease across major histocompatibihty complex barriers. Transplantation 58:602.
27. Finck, B. K , P. S. Linsley, and D. Wofsy. 1994 Treatment of murine lupus with CTLA4Ig. Science 265:7225
28. Ronchese, F , B. Hausmann, S Hubele, and P Lane. 1994 Mice transgenic for a soluble form of murine CTLA4 show enhanced expansion of antigen-specific CD4-positive T cells and defective antibody production in vivo. J. Exp. Med. 179:809
29. Perrin, P. J., D. Scott, L. Quigley, P. S Albert, O. Feder, G S. Gray, R. Abe, C. H. June, and M. K. Racke 1995. Role of B7. CD28/CTLA4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J Immunol. 154:1481
30. Freeman, G. J., D. B Lombard, C. D Gimmi, S. A. Bod, K. Lee, J. C. Laning, D A Hafler, M. E. Dorf, G. S Gray, H. Reiser, C. H June, C. B. Thompson, and L. M. Nadler. 1992. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation: expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J Immunol. 149:3795.
31. Walunas, T. L., D. J Lenschow, C Y. Bakker, P. S. Linsley, G. J. Freeman, J. M. Green, C. B. Thompson, and J A. Bluestone. 1994 CTLA4 can function as a negative regulator of T cell activation Immunity 1.405.
32. Gribben, J G., G. J. Freeman, V. A. Boussiotis, P Rennen, C. L. Jellis, E. Greenfield, M. Barber, V. A. Restivo, X. Ke, G. S. Gray, and L. M. Nadler. 1995 CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl. Acad. Sci USA 92.811.
33. Krummel, M F , and J. P. Allison. 1995. CD28 and CTLA4 have opposing effects on the response of T cells to stimulation J. Exp. Med. 182:459.
34. Schneider, H., K. V. Prasad, S. E. Shoelson, and C. E. Rudd. 1995. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med 181.351.
35. Kuchroo, V. K., M. P. Das, J A. Brown, A. M Ranger, S. S. Zamvil, R. A. Sobel, H L. Weiner, N. Nabavi, and L. H. Glimcher B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
36. Lenschow, D. J., S C. Ho, H. Sattar, L. Rhee, G. Gray, N. Nabavi, K. C Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7.1 and anti-B7.2 monoclonal antibody treatment on the development of diabetes in the non-obese diabetic mouse. J Exp Med. 181:1145.
37. Guo, Y., Y. Wu, M. Zhao, X -P. Kong, and Y. Liu. 1995. Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain. J. Exp. Med 181:1345.
38. Lewis, A. P., N. Parry, T. C. Peakman, and J. S. Crowe 1992. Rescue and expression of human immunoglobulin genes to generate functional human monoclonal antibodies. Hum. Antibodies Hybridomas 3:146.
39. Knapp, A , T. Degenhardt, and J. Dodt 1992. Huridisins. hirudin-derived thrombin inhibitors with disintegrin activity. J Biol Chcm. 267:24230.
40. Ellis, J. H., K. A. Barber, A. Tutt, H. Hale, A. P. Lewis, M. J. Glennie, G. T Stevenson, and J S Crowe 1995. Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma J. Immunol. 155:925.
41. Selvakumar, A., B. K. Mohanraj, R. L. Eddy, T. B Shows, P. C. White, and B. Dupont. 1992. Genomic organisation and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7. Immunogenetics 36:175.
42. Kirchhofer, D., J. Gailit, E. Ruoslahti, J. Grzesiak, and M. D. Pierschbacher 1990. Cation-dependent changes in the binding specificity of the platelet receptor GPIIb/IIIa. J. Biol. Chem. 265:18521.
43. Samanen, J., F. Ali, T. Romoff, R. Calvo, E Sorenson, J. Vasko, B Storer, D. Berry, D. Bennett, M. Strohsacker, D. Powers, J. Stadel, and A Nichols. 1991. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. J. Med. Chem. 34.3114.
44. 1 integrin-mediated cell adhesion. J. Biol. Chem. 268:20352.
45. Krezel, A. M., G. Wagner, J. Seymour-Ulmer, and R. A Lazarus. 1994. Structure of the RGD protein decorsin: conserved motif and distinct function in leech proteins that affect blood clotting. Science 264.1944.
46. Inobe, M., P. S. Linsley, S. A. Ledbetter, Y. Nagai, M. Tamakoshi, and T. Uede 1994. Identification of an alternatively spliced form of the murine homologue of B7. Biochem. Biophys. Res. Commun. 200:443.
47. Peach, R. J , J. Bajorath, J. Naemura, G. Leytze, J. Greene, A. Aruffo, and P Linsley. 1995. Both extracellular immunoglobulin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA4 and CD28. J. Biol. Chem. 270:21181
48. Nunes, J., S. Klasen, M. Ragueneau, C Pavon, D. Couez, C. Mawas, M. Bagnasco, and D. Olive. 1993. CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events. Int. Immunol. 5:311.
49. Lanier, L. L., S. O'Falton, C. Somoza, J. H Phillips, P. S. Linsley, K. Okumura, D. Ito, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154:97.
50. Levine, B. L., Y. Ueda, N. Craighead, M. L. Huang, and C. H. June. 1995. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4-positive T cells and induce similar patterns of cytokine secretion in vivo. Int Immunol. 7:891.
51. Linsley, P. S., J. L. Greene, W. Brady, J. Bajorath, J. A. Ledbetter, and R Peach. 1995. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA4 receptors. Immunity 1:793